韩国蛇咬伤中毒的临床特征
这项回顾性研究纳入231例韩国蛇咬伤患者,按有无横纹肌溶解(肌酸激酶≥1000 IU/L)和凝血障碍分为四组,描述中毒临床特征及抗蛇毒血清反应。90例(38.9%)发生横纹肌溶解,其中7例发生急性肾损伤(2例需肾脏替代治疗),但联合组与横纹肌溶解组急性肾损伤发生率无差异。出血发生率为3.5%,联合组与凝血障碍组无差异。约半数患者需重复给予抗蛇毒血清,主要因局部中毒效应;对进行性局部肿胀早期追加抗蛇毒血清未缩短住院时间。
要点
- 231例韩国蛇咬伤患者中90例(38.9%)发生横纹肌溶解,定义为肌酸激酶≥1000 IU/L。
- 横纹肌溶解患者中7例发生急性肾损伤,其中2例需肾脏替代治疗;联合组与横纹肌溶解组急性肾损伤发生率无差异。
- 出血发生率为3.5%,联合组与凝血障碍组出血发生率无差异。
- 约半数患者需重复给予抗蛇毒血清,主要因局部中毒效应;对进行性局部肿胀早期追加抗蛇毒血清未缩短住院时间。
- 局部肿胀范围越大预示蛇咬伤疼痛越重。
适用人群与场景
- 韩国蝮属(Gloydius)蛇咬伤患者,纳入231例;按有无横纹肌溶解和凝血障碍分为横纹肌溶解组、凝血障碍组、联合组和局部效应组。
诊断标准与关键阈值
- 横纹肌溶解定义为肌酸激酶≥1000 IU/L。
- 凝血障碍采用韩国血栓与止血学会弥散性血管内凝血评分定义。
处置流程与药物剂量
- 约半数患者需重复给予抗蛇毒血清,主要因局部中毒效应;对进行性局部肿胀早期追加抗蛇毒血清未缩短住院时间。
红旗征与不能漏的情况
- 横纹肌溶解患者可发生急性肾损伤,7例中2例需肾脏替代治疗。
- 出血发生率为3.5%。
研究设计与关键结果
- 回顾性研究纳入231例韩国蛇咬伤患者,90例(38.9%)发生横纹肌溶解。
- 联合组中重度横纹肌溶解患者的峰值肌酸激酶活性高于横纹肌溶解组。
- 7例横纹肌溶解患者发生急性肾损伤,其中2例需肾脏替代治疗;联合组与横纹肌溶解组急性肾损伤发生率无差异。
- 出血发生率为3.5%,联合组与凝血障碍组出血发生率无差异。
- 约半数患者需重复给予抗蛇毒血清,主要因局部中毒效应;对进行性局部肿胀早期追加抗蛇毒血清未缩短住院时间。
- 局部肿胀范围越大预示蛇咬伤疼痛越重。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应研究抗蛇毒血清缓解局部肿胀的能力,以避免在韩国不必要的抗蛇毒血清给药。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Three venomous snakes of the Gloydius genus belonging to the Viperidae family cause most snake envenomations in South Korea. Envenomation signs often include local swelling, coagulopathy, and rhabdomyolysis. The benefit of additional antivenom after the initial does is unclear.
METHODS: This retrospective study divided patients into four groups according to the presence of rhabdomyolysis (creatine kinase ≥1000 IU/L) and coagulopathy, which were defined using the Korean Society on Thrombosis and Hemostasis disseminated intravascular coagulation score (rhabdomyolysis, coagulopathy, combination, and local effects groups). We describe the clinical features of envenomation and the antivenom response.
RESULTS: Greater local swelling predicted more severe snakebite pain. Ninety of the 231 enrolled patients (38.9%) developed rhabdomyolysis. The patients with severe rhabdomyolysis in the combination group displayed higher peak creatine kinase activity than the rhabdomyolysis group. Seven patients with rhabdomyolysis, including two patients requiring kidney replacement therapy, developed acute kidney injury, but the incidence of acute kidney injury did not differ between the combination group and rhabdomyolysis group. Bleeding developed in 3.5% of the patients, but its incidence did not differ between the combination and coagulopathy groups. Approximately half of all patients needed repeated antivenom administration, mainly due to the local envenomation effect. Earlier administration of additional antivenom for progressive local swelling did not reduce the hospitalization duration.
CONCLUSION: Rhabdomyolysis is one of the major effects of Gloydius snake envenomation in South Korea, although it is not associated with the same risk of clinical deterioration as coagulopathy. Additionally, the ability of antivenom to ameliorate local swelling should be investigated to prevent unnecessary antivenom administration in South Korea.
参考来源
- Moon JM, Chun BJ, Cho YS, et al. Clinical features of snake envenomation in South Korea. Clin Toxicol (Phila). 2023. PMID: 36939139. doi:10.1080/15563650.2022.2160341
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。